Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t
Juliano RL. Nucleic Acid Ther. 2018 Jun;28(3):166-177. PubMed
Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement
Yan AC, Levy M. Nucleic Acid Ther. 2018 Jun;28(3):194-199. PubMed
Circular RNAs in Cancer – Lessons Learned From microRNAs
Dragomir M, Calin GA. Front Oncol. 2018 May 28;8:179. PubMed
Recent Preclinical and Clinical Advances in Oligonucleotide Conjugates
Craig K, Abrams M, Amiji M. Expert Opin Drug Deliv. 2018 May 4. PubMed
Tapping the RNA world for therapeutics
Lieberman J. Nat Struct Mol Biol. 2018 May;25(5):357-364. PubMed
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
McClorey G, Banerjee S. Biomedicines. 2018 May 5;6(2). PubMed
Extrahepatic Targeting of Oligonucleotides with Receptor-Binding Non-immunoglobulin Scaffold Proteins
Winkler J. Nucleic Acid Ther. 2018 May 7. PubMed
Improving Small Interfering RNA Delivery In Vivo Through Lipid Conjugation
Osborn MF, Khvorova A. Nucleic Acid Ther. 2018 May 10. PubMed
Clinical utility of circulating non-coding RNAs – an update
Anfossi S, Babayan A, Pantel K, Calin GA. Nat Rev Clin Oncol. 2018 May 21. PubMed
Artificially Expanded Genetic Information Systems for New Aptamer Technologies
Biondi E, Benner SA. Biomedicines. 2018 May 9;6(2). pii: E53. PubMed